Inhaled nitric oxide in sickle cell disease with acute chest syndrome

Anesthesiology

Volumn 87, Issue 4, 1997, Pages 988-990

  Atz, Andrew M ^a   Wessel, David L ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

Acute chest syndrome; Inhaled nitric oxide; Sickle cell disease

Indexed keywords

NITRIC OXIDE;

ARTICLE; CASE REPORT; CHILD; EDEMA; EFFUSION; FEMALE; FEVER; HUMAN; LUNG INFILTRATE; MALE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SYNDROME; THORAX PAIN;

ADMINISTRATION, INHALATION; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NITRIC OXIDE; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0030669447     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199710000-00037     Document Type: Article

References (15)

1. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH Klug PP: Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330:1639-44
2. Emre U, Miller ST, Gutierez M, Steiner P, Rao SP, Rao M: Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr 1995; 127:901-4
3. Natarajan M, Udden MM, McIntire LV: Adhesion of sickle red blood cells and damage to interleukin-1 beta stimulated endothelial cells under flow in vitro. Blood 1996; 87:4845-52
4. Phelan M, Perrine SP, Brauer M, Faller DV: Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture. J Clin Invest 1995; 96:1145-51
5. Mosseri M, Bartlett-Pandite AN, Wenc K, Isner JM, Weinstein R: Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes. Am Heart J 1993; 126:338-46
6. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ: Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88(part I):2128-38
7. Hammond TG, Mosesson MW: Fatal small-bowel necrosis and pulmonary hypertension in sickle cell disease. Arch Intern Med 1989; 149:447-8
8. Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW: Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: Possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest 1980; 65:154-60
9. Chiu D, Lubin B, Roelofsen B, van Deenen LL: Sickled erythrocytes accelerate clotting in vitro: An effect of abnormal membrane asymmetry. Blood 1981; 58:398-401
10. Dias-Da-Motta PM, Arruda VR, Muscara MN, Saad ST, De Nucci G, Costa FF, Condino-Neto A: The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia. Br J Haematol 1996; 93:333-40
11. Bigatello LM, Hurford WE, Kacmarek RM, Roberts JDJ, Zapol WM: Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. ANESTHESIOLOGY 1994; 80:761-70
12. Lowson SM, Rich GF, McArdle PA, Jaidev J, Morris GN: The response to varying concentrations of inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesth Analg 1996; 82:574-81
13. Samama CM, Diaby M, Fellahi J, Mdhafar A, Eyraud D, Arock M, Guillosson JJ, Coriat P, Rouby JJ: Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. ANESTHESIOLOGY 1995; 83:56-65
14. Yoshida K, Kasama K: Biotransformation of nitric oxide. Envir Health Persp 1987; 73:201-5
15. 2, NO, and isocyanides. J Am Chem Soc 1988; 110:380-7